Efficacy and safety of 177 Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.
Dominique S V M ClementShaunak NavalkissoorRajaventhan SrirajaskanthanFrédéric CourbonLawrence O DierickxAmy EcclesValerie LewingtonMercedes MitjavilaJuan Carlos PercovichBenoît LequoyBeilei HeIlya FolitarJohn K RamagePublished in: European journal of nuclear medicine and molecular imaging (2022)
Lu-DOTATATE for the treatment of patients with advanced, somatostatin receptor-positive panNETs.